Geneticure Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 9

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $24.5K

  • Investors
  • 12

Geneticure General Information

Description

Developer of pharmacogenomic tests designed to help predict treatment methods for chronic and dangerous diseases. The company's tests use multi-gene, disease-specific genomic panels, supported by clinical evidence that helps doctors and clinicians create personalized and patient-specific treatments for controlling high blood pressure and hypertension, enabling patients to have painless and affordable at-home tests to achieve their blood pressure goals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 4 3rd Street Southwest
  • Suite 305b
  • Rochester, MN 55902
  • United States
+1 (800) 000-0000

Geneticure Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geneticure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 27-Apr-2020 $24.5K 00.00 Completed Generating Revenue
7. Seed Round 01-Jan-2019 00.000 00.00 Completed Generating Revenue
6. Seed Round 17-Aug-2017 00000 00.000 Completed Generating Revenue
5. Seed Round 01-Apr-2017 00.000 00.000 Completed Generating Revenue
4. Seed Round 18-Oct-2016 00000 00.000 Completed Generating Revenue
3. Grant 25-Sep-2016 0000 00000 Completed Generating Revenue
2. Accelerator/Incubator $186K Completed Generating Revenue
1. Angel (individual) 15-Aug-2014 $186K $186K Completed Generating Revenue
To view Geneticure’s complete valuation and funding history, request access »

Geneticure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of pharmacogenomic tests designed to help predict treatment methods for chronic and dangerous diseases. The co
Diagnostic Equipment
Rochester, MN
9 As of 2022
00.00
0000000000 00.00

000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000000
King of Prussia, PA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

000000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000000000 000000000
Charleston, SC
0 As of 0000
00.000
0000000000.
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Geneticure Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomind Venture Capital-Backed King of Prussia, PA 00 000.00 00000000000 000.00
0000000 0000000 00 Formerly VC-backed Charleston, SC 0 00.000 0000000000.
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
000000 Venture Capital-Backed Minneapolis, MN 00 00.000 0000000000 0 00.000
0000000 Corporate Backed or Acquired Seattle, WA 00 000000&0
You’re viewing 5 of 9 competitors. Get the full list »

Geneticure Patents

Geneticure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3728637-A1 Method for treatment of hypertension Pending 21-Dec-2017 0000000000
US-20200299771-A1 Machine assay and analysis for selecting antihypertensive drugs Pending 29-May-2014 0000000000
EP-3149487-B1 Improved therapeutic regimen for hypertension Active 29-May-2014 0000000000
EP-3149487-A1 Improved therapeutic regimen for hypertension Active 29-May-2014 0000000000
US-20180195128-A1 Therapeutic regimen for hypertension Active 29-May-2014 C12Q1/6883
To view Geneticure’s complete patent history, request access »

Geneticure Executive Team (7)

Name Title Board Seat Contact Info
Scott Snyder Co-Founder, President, Chief Executive Officer & Board Member
Eric Snyder Ph.D Co-Founder & Chief Operating Officer
Ryan Sprissler Ph.D Co-Founder & Chief Scientific Officer
Thomas Olson Ph.D Co-Founder & Chief Clinical Officer
David Herbert Executive Vice President of Strategy
You’re viewing 5 of 7 executive team members. Get the full list »

Geneticure Board Members (1)

Name Representing Role Since
Scott Snyder Geneticure Co-Founder, President, Chief Executive Officer & Board Member 000 0000
To view Geneticure’s complete board members history, request access »

Geneticure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geneticure Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Minnesota Department of Employment and Economic Development Government 000 0000 000000 0
Mayo Clinic Ventures Venture Capital Minority 000 0000 000000 0
Southeast Minnesota Capital Fund Venture Capital Minority 000 0000 000000 0
University of St. Thomas Minnesota Endowment Limited Partner Minority 000 0000 000000 0
M25 Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »